FDA submission to OMB for Paperwork Reduction Act review of information collection requirements for dietary supplement manufacturing, packaging, labeling, and holding operations.
FDA requests OMB clearance for information collection activities related to Current Good Manufacturing Practice regulations for Type A medicated articles and medicated feeds under the Paperwork Reduction Act of 1995.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
The U.S. Department of Commerce finds finished carbon steel flanges from India were dumped in the United States during August 1, 2023 through July 31, 2024, triggering antidumping duty assessments.
Foreign-Trade Zone 38 subzone application for ElringKlinger South Carolina, LLC in Easley allows duty-free importation of automotive components for manufacturing and re-export.
The FDA renews its Science Board advisory committee for an additional two years, with the new charter expiring June 26, 2028.
FDA withdraws approval of SpecGx LLC's abbreviated new drug application for Methylphenidate Hydrochloride Extended-Release tablets in 27mg, 36mg, and 54mg strengths per the applicant's request.
FDA issues Emergency Use Authorizations for two animal drugs to prevent and treat New World screwworm infestations in livestock, poultry, and exotic animals following HHS's August 18, 2025 public health emergency declaration.
U.S. Department of Commerce issues countervailing duty orders on certain chassis and subassemblies from Mexico and Thailand following affirmative trade injury determinations.
HUD seeks OMB approval for a public housing waiting list data collection tool under the Housing Opportunity Through Modernization Act; public comment period ends 30 days from publication.
FDA seeks 60 days of public comment on information collection requirements for extralabel drug use in animals under the Paperwork Reduction Act.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
